Health tech stocks are hemorrhaging, according to Rock Health, which found that publicly traded digital health securities plummeted 38% between the start of Q3'21 and the end of Q1'22.
Why it matters: It's no secret that the public markets have been volatile, but when compared with the S&P 500 — which dropped just 5% over the same period — this tumble clearly stands out.
